What is the next step in management for a 35-year-old man with a 6‑month left axillary soft‑tissue swelling, ultrasound showing a 3.2 × 1.9 × 2.0 cm hypoechoic lesion with irregular margins, an adjacent axillary lymph node with 0.4 cm cortical thickening, and a 1.3 × 0.7 × 0.8 cm calcific focus inferior to the lesion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Left Axillary Soft Tissue Mass with Suspicious Features

This patient requires urgent referral to a specialist sarcoma multidisciplinary team (MDT) within 2 weeks and should undergo MRI with contrast of the affected region before any biopsy is performed. 1, 2

Critical Red Flags Present

This presentation contains multiple concerning features that mandate specialist evaluation:

  • Deep soft tissue mass measuring 3.2 cm meets size criteria for urgent cancer pathway referral 1
  • Irregular borders on ultrasound are highly suspicious for malignancy and contraindicate simple observation 1, 2
  • Adjacent lymph node with cortical thickening (0.4 cm) suggests potential nodal involvement, which occurs in certain sarcoma subtypes including synovial sarcoma and epithelioid sarcoma 1, 2
  • Calcific focus inferior to the lesion is present in approximately 27% of proven soft tissue masses and can be a marker of sarcoma 1, 2
  • Six-month duration with persistent swelling indicates a progressive process requiring definitive diagnosis 1

Immediate Next Steps

1. Urgent MRI with Contrast (Before Biopsy)

MRI with contrast is the mandatory next imaging study and must be obtained before any tissue sampling. 1, 2

  • MRI provides superior soft tissue contrast resolution and multiplanar capability essential for characterizing the lesion, assessing neurovascular involvement, and planning surgical approach 1, 2
  • MRI is the technique of choice for detecting and characterizing soft tissue masses in the axilla, offering the most accurate assessment of compartment anatomy and relationship to critical structures 2
  • Performing a biopsy before MRI can seed tumor cells along the tract, compromise surgical margins, and worsen functional and survival outcomes 2

2. Specialist Sarcoma MDT Referral

Refer immediately via suspected cancer pathway for appointment within 2 weeks. 1

  • All patients with ultrasound findings suggestive of soft tissue sarcoma (irregular borders, deep location, adjacent lymph node involvement) require specialist MDT management 1
  • The MDT should include pathologists, radiologists, surgeons, radiation therapists, and medical oncologists with sarcoma expertise 1
  • Decisions about biopsy technique, timing, and tract placement must be made by the sarcoma MDT to ensure the biopsy tract can be safely removed during definitive surgery 1, 2

3. Staging Investigations

CT chest should be performed to exclude pulmonary metastases, as soft tissue sarcomas have a predominant pattern of lung metastases 1, 2

Additional staging considerations based on final histology:

  • Regional lymph node assessment by ultrasound or cross-sectional imaging is particularly important given the cortical thickening already identified, especially if synovial sarcoma, clear cell sarcoma, angiosarcoma, or epithelioid sarcoma is suspected 1, 2
  • PET-CT may be considered before radical surgery in selected cases, though it is not yet proven as routine investigation 1

Biopsy Planning (Only After MRI and MDT Review)

Percutaneous core needle biopsy is the standard approach once imaging is complete and MDT planning has occurred. 1, 2

  • Multiple cores should be taken under image guidance to maximize diagnostic yield 1
  • The biopsy tract must be planned so it can be excised en-bloc with the definitive resection 2
  • Fine needle aspiration is not recommended as a primary diagnostic modality 1

Critical Pitfalls to Avoid

  • Never perform excisional biopsy or any tissue sampling before MRI and specialist consultation - this can lead to inadequate margins, tumor spillage, and need for more extensive re-resection, adversely affecting functional outcome and survival 2
  • Do not rely on ultrasound characteristics alone to exclude malignancy - while ultrasound has high sensitivity (94.1%) and specificity (99.7%) for superficial masses, irregular borders and deep location require definitive cross-sectional imaging 1
  • Do not delay referral pending additional imaging - refer simultaneously while ordering MRI to expedite specialist evaluation 1

Differential Diagnosis Considerations

While awaiting definitive diagnosis, the differential includes:

  • Soft tissue sarcoma (various subtypes given irregular borders and calcification) 1, 2
  • Lymphoma (given axillary location and adjacent lymph node involvement) 1, 3
  • Atypical lipomatous tumor (though irregular borders make simple lipoma unlikely) 1
  • Infectious/inflammatory process (though 6-month duration without systemic symptoms makes this less likely) 1, 4

The presence of irregular borders, calcification, and lymph node involvement strongly favors a neoplastic process requiring tissue diagnosis. 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management Approach for Suspicious Soft Tissue Mass in the Thigh

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Axillary swelling and a reduced general condition in a middle-aged man.

Nature clinical practice. Oncology, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.